17:HKEXWILL SMART CO LTD Analysis
Data as of 2026-07-26 - not real-time
HK$0.95
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
DL Holdings is trading well below its longer‑term moving averages, with the current price under the 20‑day, 50‑day and 200‑day trends, signaling a bearish technical backdrop. The Relative Strength Index sits in oversold territory, while the MACD remains in a bearish configuration, suggesting limited upside momentum in the near term. Fundamentally, the company boasts a price‑to‑earnings multiple that is markedly lower than its sector peers and a price‑to‑book ratio beneath one, indicating potential valuation headroom. However, operating margins are negative, cash‑flow generation is absent and the debt‑to‑equity ratio is elevated, raising concerns about financial resilience. Recent annual results disclosed a substantial jump in net profit and revenue, alongside an ambitious dividend distribution that includes cash, asset‑linked payouts and bonus shares, pointing to improving earnings but also to a reliance on non‑cash components. The combination of a low valuation, strong earnings growth and high leverage creates a mixed picture, where upside may be possible if cash‑flow generation improves, yet downside risk remains elevated due to the bearish technical stance and volatility.
Investors should weigh the attractive valuation and recent profit surge against the weak cash‑flow profile, high leverage and deteriorating price trend. The prevailing market sentiment is exuberant, as reflected by an extreme greed index, which may further pressure the stock downward in the short run. A cautious approach is advisable, with potential for a longer‑term re‑rating if the company can translate earnings into sustainable cash flow and reduce its debt burden.
Investors should weigh the attractive valuation and recent profit surge against the weak cash‑flow profile, high leverage and deteriorating price trend. The prevailing market sentiment is exuberant, as reflected by an extreme greed index, which may further pressure the stock downward in the short run. A cautious approach is advisable, with potential for a longer‑term re‑rating if the company can translate earnings into sustainable cash flow and reduce its debt burden.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- price below key moving averages
- bearish MACD and low RSI
- decreasing volume and high short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- substantial earnings growth reported in latest results
- persistent cash‑flow shortfall
- elevated leverage limiting upside
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- deep valuation discount relative to peers
- potential for cash‑flow conversion as earnings improve
- large asset base and diversified service lines
Key Metrics & Analysis
Financial Health
Revenue Growth83.20%
Profit Margin118.43%
P/E Ratio4.5
ROE20.02%
ROA15.82%
Debt/Equity14.86
P/B Ratio0.7
Industry P/E17.8
Technical Analysis
TrendBearish
RSI30.8
SupportHK$0.92
ResistanceHK$1.20
MA 20HK$1.04
MA 50HK$1.12
MA 200HK$1.72
MACDBearish
VolumeDecreasing
Fear & Greed Index88.25
Valuation
GradeUndervalued
TypeBlend
Dividend Yield1.04%
Risk Assessment
Beta0.75
Volatility38.30%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.